Additional file 1 of Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

Khunti, Kamlesh; Kosiborod, Mikhail; Kim, Dae Jung; Kohsaka, Shun; Lam, Carolyn S. P.; Goh, Su-Yen; Chiang, Chern-En; Shaw, Jonathan E.; Cavender, Matthew A.; Tangri, Navdeep; Franch-Nadal, Josep; Holl, Reinhard W.; Jørgensen, Marit E.; Norhammar, Anna; Eriksson, Johan G.; Zaccardi, Francesco; Karasik, Avraham; Magliano, Dianna J.; Thuresson, Marcus; Chen, Hungta; Wittbrodt, Eric; Bodegård, Johan; Surmont, Filip; Fenici, Peter

doi:10.6084/m9.figshare.15087347.v1

12933_2021_1345_MOESM1_ESM.docx (518.37 kB)

Additional file 1 of Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

journal contribution

posted on 2021-08-01, 03:19 authored by Kamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim, Shun Kohsaka, Carolyn S. P. Lam, Su-Yen Goh, Chern-En Chiang, Jonathan E. Shaw, Matthew A. Cavender, Navdeep Tangri, Josep Franch-Nadal, Reinhard W. Holl, Marit E. Jørgensen, Anna Norhammar, Johan G. Eriksson, Francesco Zaccardi, Avraham Karasik, Dianna J. Magliano, Marcus Thuresson, Hungta Chen, Eric Wittbrodt, Johan Bodegård, Filip Surmont, Peter Fenici

Additional file 1. CVD-REAL Investigator and Study Group.

Funding

AstraZeneca

History

Usage metrics

Keywords

Sodium–glucose cotransporter-2 inhibitors Cardiovascular outcomes Heart failure Type 2 diabetes

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

Funding

AstraZeneca

History

Usage metrics

Categories

Keywords

Licence

Exports